Corcept Therapeutics Incorporated
CORT
Rangering i aksjer
#1694
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo... Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for adult patients diagnosed with endogenous Cushing's syndrome who suffer from hyperglycemia due to hypercortisolism, particularly those with type 2 diabetes or glucose intolerance, and for whom surgical options have either failed or are not viable. The company's development pipeline is robust, featuring relacorilant, which is being advanced for Cushing's syndrome. It is also investigating a combination of relacorilant with nab-paclitaxel; this pairing has concluded Phase II clinical trials for advanced ovarian tumors and is additionally being studied for conditions involving cortisol excess. Furthermore, Corcept is developing distinct selective cortisol modulators for specific indications such as metastatic castration-resistant prostate cancer and antipsychotic-induced weight gain, alongside research into FKBP5 gene expression assays.
Aksjekurs
$116.44
Markedsverdi
$12.59B
Endring (1 dag)
3.87%
Endring (1 år)
48.14%
Land
US
Handel Corcept Therapeutics Incorporated (CORT)
Kategori
Healthcare
Historikk for aksjesplitt for Corcept Therapeutics Incorporated (CORT)
Aksjen Corcept Therapeutics Incorporated (symbol: CORT) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én CORT-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 CORT-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én CORT-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 CORT-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 0 | - |
US
|
|
| 0 | - |
SE
|
|
| 0 | - |
FR
|
|
| 0 | - |
IT
|
|
| 7 | x40 |
HK
|
